Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ADALIMUMAB Cause Impaired driving ability? 136 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 136 reports of Impaired driving ability have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.0% of all adverse event reports for ADALIMUMAB.

136
Reports of Impaired driving ability with ADALIMUMAB
0.0%
of all ADALIMUMAB reports
1
Deaths
50
Hospitalizations

How Dangerous Is Impaired driving ability From ADALIMUMAB?

Of the 136 reports, 1 (0.7%) resulted in death, 50 (36.8%) required hospitalization, and 1 (0.7%) were considered life-threatening.

Is Impaired driving ability Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 136 reports have been filed with the FAERS database.

What Other Side Effects Does ADALIMUMAB Cause?

Drug ineffective (71,926) Pain (37,514) Arthralgia (35,592) Rheumatoid arthritis (29,817) Fatigue (29,420) Injection site pain (28,679) Headache (19,891) Nausea (19,299) Rash (18,690) Pain in extremity (18,319)

What Other Drugs Cause Impaired driving ability?

OXYCODONE (702) PREGABALIN (440) LEVOTHYROXINE (257) MORPHINE (247) ACETAMINOPHEN\HYDROCODONE (223) FENTANYL (222) ACETAMINOPHEN\OXYCODONE (211) GABAPENTIN (194) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (177) ALPRAZOLAM (155)

Which ADALIMUMAB Alternatives Have Lower Impaired driving ability Risk?

ADALIMUMAB vs ADALIMUMAB-AACF ADALIMUMAB vs ADALIMUMAB-AATY ADALIMUMAB vs ADALIMUMAB-ADAZ ADALIMUMAB vs ADALIMUMAB-ADBM ADALIMUMAB vs ADALIMUMAB-AFZB

Related Pages

ADALIMUMAB Full Profile All Impaired driving ability Reports All Drugs Causing Impaired driving ability ADALIMUMAB Demographics